Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Gross Profit (2019 - 2025)

Pulmonx (LUNG) has disclosed Gross Profit for 7 consecutive years, with $16.1 million as the latest value for Q3 2025.

  • Quarterly Gross Profit rose 6.83% to $16.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $67.2 million through Sep 2025, up 14.24% year-over-year, with the annual reading at $62.0 million for FY2024, 22.16% up from the prior year.
  • Gross Profit for Q3 2025 was $16.1 million at Pulmonx, down from $17.2 million in the prior quarter.
  • The five-year high for Gross Profit was $17.6 million in Q4 2024, with the low at $6.6 million in Q1 2021.
  • Average Gross Profit over 5 years is $12.5 million, with a median of $12.7 million recorded in 2023.
  • The sharpest move saw Gross Profit skyrocketed 792.19% in 2021, then rose 4.24% in 2022.
  • Over 5 years, Gross Profit stood at $10.3 million in 2021, then grew by 9.1% to $11.2 million in 2022, then rose by 28.76% to $14.4 million in 2023, then increased by 22.15% to $17.6 million in 2024, then fell by 8.74% to $16.1 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $16.1 million, $17.2 million, and $16.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.